Complete Dose Comparison: Mounjaro vs Wegovy Journey
Understanding Mounjaro and Wegovy Equivalent Doses Across Treatment Phases
When comparing Mounjaro and Wegovy equivalent doses, both treatments follow identical escalation schedules despite their different mechanisms of action. Mounjaro (tirzepatide) works as a dual GIP and GLP-1 receptor agonist, whilst Wegovy (semaglutide) targets GLP-1 receptors exclusively. Both begin at 0.25mg weekly for the first four weeks, then progress through 0.5mg, 1mg, and 1.7mg phases before reaching the 2.4mg maintenance dose. This systematic approach helps minimise gastrointestinal side effects whilst optimising treatment efficacy.
At EverydayMeds, we understand that treatment journeys extend beyond initial prescription—patients need reliable access to every dose throughout their weight management programme. Our comprehensive stock ensures seamless progression from starter doses through long-term maintenance, eliminating the frustration of pharmacy switching mid-treatment. Both Wegovy and Mounjaro are prescription-only medicines that require clinical assessment and ongoing prescriber support throughout the dose escalation process.
Wegovy Pricing Structure: Complete Mounjaro and Wegovy Equivalent Doses Cost Analysis
Our Wegovy pricing reflects the complete treatment journey, with single pens ranging from £79.99 for the 0.25mg starter dose to £209.99 for the 2.4mg maintenance dose. New customers apply discount code FIRST40 at checkout to reach these final prices, whilst returning patients use code DOSE25. Our Intro Trio bundle provides the first three doses (0.25mg, 0.5mg, and 1mg) for £299.99, covering weeks 1-12 of treatment. The Ultimate Stability Trio offers three months of 2.4mg maintenance supply for £649.99, ideal for patients established on their target dose.
Bundle pricing emphasises convenience and supply security rather than cost savings alone—our 2-pen Getting Started Bundles ensure patients have their next dose ready without reordering delays. The Progress Duo (0.5mg and 1mg) costs £189.99 and covers the crucial weeks 5-12 transition period. All orders include next-day cold-chain delivery once prescriber approval is received, maintaining the medication's efficacy from our GPhC-registered facility to your door.
Clinical Evidence Supporting Mounjaro and Wegovy Equivalent Doses Effectiveness
The STEP clinical trial programme demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo in STEP 1. STEP 2 showed 9.6% average weight loss in patients with type 2 diabetes, whilst STEP 3 achieved 16% when combined with intensive behavioural therapy. The recent SELECT trial additionally demonstrated a 20% reduction in major cardiovascular events (hazard ratio 0.80) in patients with established cardiovascular disease.
Mounjaro's SURMOUNT trials showed similar efficacy patterns, though direct head-to-head comparisons between Mounjaro and Wegovy equivalent doses haven't been conducted due to different trial designs and patient populations. Both treatments require the same systematic dose escalation to achieve optimal results whilst minimising side effects. Long-term data from STEP 5 confirmed sustained 15.2% average weight loss at two years, emphasising the importance of continued treatment for maintained benefits.
How Wegovy Works: GLP-1 Mechanism in Mounjaro and Wegovy Equivalent Doses
Wegovy (semaglutide) functions as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates appetite and food intake. When administered weekly, it binds to GLP-1 receptors in the brain's appetite centres, promoting feelings of fullness and reducing food cravings between meals. The medication also slows gastric emptying, helping patients feel satisfied with smaller portions. This mechanism works alongside a reduced-calorie diet and increased physical activity to support sustainable weight management. The dose escalation from 0.25mg to 2.4mg allows patients to adapt gradually whilst the medication builds therapeutic levels in their system.
Streamlined Ordering Process for Mounjaro and Wegovy Equivalent Doses
Our ordering process begins with a comprehensive 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Once submitted, our prescribers review applications within 3 working days (or 24 hours with express service) to ensure treatment suitability and determine appropriate starting doses. Upon approval, orders are dispatched via next-day delivery using specialised cold-chain packaging that maintains the 2-8°C temperature requirement. Our GPhC-registered pharmacy (#9012878) ensures all medications meet MHRA standards for quality and authenticity. Patients receive tracking information and temperature monitoring data with each delivery, providing confidence in medication integrity throughout the supply chain.
Storage and Practical Considerations for Mounjaro and Wegovy Equivalent Doses
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, whilst Mounjaro requires return to cold storage after 21 days. Both medications arrive in pre-filled FlexTouch pens requiring refrigerated storage at 2-8°C before first use. The weekly injection schedule allows for flexible timing within the same day each week, accommodating varying lifestyle commitments. Dose escalation cannot be accelerated—patients must complete each 4-week phase before progressing, allowing the body to adapt and minimising gastrointestinal side effects. Our patient support team provides injection technique guidance and storage reminders to optimise treatment outcomes.
Complete Treatment Journey: Why All Mounjaro and Wegovy Equivalent Doses Matter
Weight management treatment extends far beyond initial prescription—successful outcomes depend on consistent access to every dose throughout the escalation and maintenance phases. Many patients experience supply interruptions when their original pharmacy cannot stock higher doses, forcing treatment gaps or provider changes at critical progression points. Our commitment to maintaining complete inventory means patients begin their journey confident that we'll support them through 2.4mg maintenance and beyond.
The psychological benefit of treatment continuity cannot be understated—patients develop relationships with their prescribing team and understand our delivery systems, reducing anxiety around prescription renewals. Our bundle options reflect real-world treatment patterns, with the Gentle Start Trio (0.25mg, 0.25mg, 0.5mg) accommodating patients who need extended time on the lowest dose. This comprehensive approach distinguishes us from limited-stock providers who may only carry common starter doses.
Expert Prescriber Support for Mounjaro and Wegovy Equivalent Doses Selection
Both Wegovy and Mounjaro are available from EverydayMeds, and our clinical team can help determine which treatment aligns with your individual circumstances and medical history. Our prescribers consider factors including previous GLP-1 experience, concurrent medications, and specific weight management goals when recommending between these prescription-only medicines. Initial consultations explore patient preferences around injection frequency, storage requirements, and side effect profiles to optimise treatment selection. Ongoing support includes dose adjustment guidance, side effect management, and long-term maintenance planning. New patients can begin their assessment today using discount code FIRST40, whilst existing patients continue their journey with code DOSE25 at https://everydaymeds.co.uk/collections/wegovy, ensuring seamless access to their complete treatment pathway under expert clinical supervision.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
